Danaher Corporation (0R2B.L)
USD 230.79
(-1.77%)
USD 230.79
(-1.77%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 19.35 Billion USD | -6.11% |
| 2022 | 20.61 Billion USD | -11.41% |
| 2021 | 23.27 Billion USD | 4.93% |
| 2020 | 22.17 Billion USD | -1.54% |
| 2019 | 22.52 Billion USD | 131.27% |
| 2018 | 9.74 Billion USD | -7.43% |
| 2017 | 10.52 Billion USD | -14.24% |
| 2016 | 12.26 Billion USD | -4.67% |
| 2015 | 12.87 Billion USD | 270.54% |
| 2014 | 3.47 Billion USD | -0.73% |
| 2013 | 3.49 Billion USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 18.82 Billion USD | 3.37% |
| 2024 Q2 | 18.21 Billion USD | -5.47% |
| 2024 Q1 | 19.26 Billion USD | -1.4% |
| 2023 Q2 | 20.97 Billion USD | 0.21% |
| 2023 FY | 19.53 Billion USD | -5.24% |
| 2023 Q4 | 19.53 Billion USD | -15.65% |
| 2023 Q1 | 20.93 Billion USD | 0.93% |
| 2023 Q3 | 23.16 Billion USD | 10.42% |
| 2022 Q4 | 20.73 Billion USD | 7.75% |
| 2022 FY | 20.61 Billion USD | -11.41% |
| 2022 Q3 | 19.24 Billion USD | -4.06% |
| 2022 Q2 | 20.06 Billion USD | -7.88% |
| 2022 Q1 | 21.77 Billion USD | -6.42% |
| 2021 Q1 | 21.25 Billion USD | -3.34% |
| 2021 FY | 23.27 Billion USD | 4.93% |
| 2021 Q3 | 23.59 Billion USD | 15.55% |
| 2021 Q4 | 23.27 Billion USD | -1.38% |
| 2021 Q2 | 20.42 Billion USD | -3.91% |
| 2020 Q1 | 26.83 Billion USD | 19.95% |
| 2020 Q3 | 22.76 Billion USD | -2.24% |
| 2020 FY | 22.17 Billion USD | -1.54% |
| 2020 Q4 | 21.98 Billion USD | -3.39% |
| 2020 Q2 | 23.28 Billion USD | -13.23% |
| 2019 Q1 | 10.29 Billion USD | 5.69% |
| 2019 FY | 22.52 Billion USD | 131.27% |
| 2019 Q4 | 22.36 Billion USD | 21.0% |
| 2019 Q3 | 18.48 Billion USD | 66.73% |
| 2019 Q2 | 11.08 Billion USD | 7.7% |
| 2018 Q4 | 9.74 Billion USD | -8.26% |
| 2018 Q2 | 11.32 Billion USD | 7.72% |
| 2018 Q1 | 10.5 Billion USD | -0.12% |
| 2018 FY | 9.74 Billion USD | -7.43% |
| 2018 Q3 | 10.61 Billion USD | -6.21% |
| 2017 Q2 | 11.59 Billion USD | -3.0% |
| 2017 FY | 10.52 Billion USD | -14.24% |
| 2017 Q1 | 11.95 Billion USD | -2.6% |
| 2017 Q3 | 10.9 Billion USD | -5.89% |
| 2017 Q4 | 10.52 Billion USD | -3.55% |
| 2016 Q1 | 12.39 Billion USD | -3.72% |
| 2016 FY | 12.26 Billion USD | -4.67% |
| 2016 Q3 | 8.31 Billion USD | -43.27% |
| 2016 Q4 | 12.26 Billion USD | 47.6% |
| 2016 Q2 | 14.65 Billion USD | 18.24% |
| 2015 Q4 | 12.87 Billion USD | -14.27% |
| 2015 Q1 | 3.17 Billion USD | -8.52% |
| 2015 Q3 | 15.01 Billion USD | 374.64% |
| 2015 Q2 | 3.16 Billion USD | -0.46% |
| 2015 FY | 12.87 Billion USD | 270.54% |
| 2014 Q4 | 3.47 Billion USD | 14.4% |
| 2014 Q3 | 3.03 Billion USD | -1.07% |
| 2014 Q2 | 3.06 Billion USD | -11.99% |
| 2014 Q1 | 3.48 Billion USD | -0.34% |
| 2014 FY | 3.47 Billion USD | -0.73% |
| 2013 FY | 3.49 Billion USD | 0.0% |
| 2013 Q1 | 4.47 Billion USD | 0.0% |
| 2013 Q4 | 3.49 Billion USD | -0.09% |
| 2013 Q2 | 4.15 Billion USD | -7.08% |
| 2013 Q3 | 3.5 Billion USD | -15.71% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -161428.833% |
| Accuray Incorporated | 172.15 Million USD | -11143.291% |
| Align Technology, Inc. | 96.96 Million USD | -19861.224% |
| Elevance Health Inc. | 25.12 Billion USD | 22.946% |
| AxoGen, Inc. | 69.29 Million USD | -27833.961% |
| Boston Scientific Corporation | 9.09 Billion USD | -112.773% |
| CVS Health Corporation | 79.38 Billion USD | 75.618% |
| Cardinal Health, Inc. | 5.6 Billion USD | -245.088% |
| Centene Corporation | 17.69 Billion USD | -9.362% |
| DaVita Inc. | 11.11 Billion USD | -74.121% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 53.759% |
| Hologic, Inc. | 2.53 Billion USD | -663.671% |
| Humana Inc. | 10.21 Billion USD | -89.523% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -1942.031% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | -225.081% |
| Masimo Corporation | 970 Million USD | -1895.464% |
| McKesson Corporation | 5.47 Billion USD | -253.728% |
| Patterson Companies, Inc. | 762.94 Million USD | -2437.028% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | -260.514% |
| ResMed Inc. | 873.93 Million USD | -2114.81% |
| Henry Schein, Inc. | 2.74 Billion USD | -606.166% |
| Teladoc Health, Inc. | 1.59 Billion USD | -1115.618% |
| Universal Health Services, Inc. | 5.36 Billion USD | -260.673% |
| Veeva Systems Inc. | 55.77 Million USD | -34603.72% |
| Baxter International Inc. | 14.36 Billion USD | -34.754% |
| Becton, Dickinson and Company | 15.87 Billion USD | -21.897% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -21454.566% |
| Stryker Corporation | 12.99 Billion USD | -48.95% |
| Medtronic plc | 24.96 Billion USD | 22.461% |